Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


International Journal of Experimental and Clinical Chemotherapy

Vol. 57, No. 2, 2011

Issue release date: April 2011

Add all to MyReading List

Urinary Pharmacokinetics and Bactericidal Activity of Finafloxacin (200 and 800 mg) in Healthy Volunteers Receiving a Single Oral Dose

Wagenlehner F.M.E. · Wagenlehner C.M. · Blenk B. · Blenk H. · Schubert S. · Dalhoff A. · Naber K.G.
Chemotherapy 2011;57:97–107 (DOI:10.1159/000321028)
Clinical Study

Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Kim S.T. · Choi Y.J. · Park K.H. · Oh S.C. · Seo J.H. · Shin S.W. · Kim J.S. · Kim Y.H.
Chemotherapy 2011;57:108–114 (DOI:10.1159/000321490)

Castration-Resistant Prostate Cancer: Targeted Therapies

Leo S. · Accettura C. · Lorusso V.
Chemotherapy 2011;57:115–127 (DOI:10.1159/000323581)
Experimental Chemotherapy

In vitro Activities of Erythromycin, Tetracycline and Levofloxacin Alone and in Dual Combinations against Ureaplasma spp.

Luo D.-Q. · Liu J.-Y. · Yang W. · Zhang B. · Yu M.-J. · Wu Y.-M.
Chemotherapy 2011;57:128–133 (DOI:10.1159/000323629)
Clinical Study

Cefepime Resistance and Associated Risk Factors among Escherichia coli Strains Isolated from Clinical Specimens

Mansouri M. · Ramazanzadeh R. · Norabadi P.
Chemotherapy 2011;57:134–137 (DOI:10.1159/000323623)

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

Feliu Batlle J. · Cuadrado E. · Castro J. · Caldés T. · Belda C. · Sastre J. · Barriuso J. · Martínez Marín V. · Díaz-Rubio E. · González-Barón M.
Chemotherapy 2011;57:138–144 (DOI:10.1159/000323624)
Letter to the Editor

Unity Is Strength

Maunoury V. · Mordon S. · Bulois P.
Chemotherapy 2011;57:145–146 (DOI:10.1159/000326914)

Low-Dose Weekly Docetaxel Is as Tolerable as Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

Chung F.-T. · Lee K.-Y. · Fang Y.-F. · Shieh M.-H. · Lin S.-M. · Yu C.-T. · Lo Y.-L. · Lin T.-Y. · Kuo C.-H. · Feng P.-H. · Ni Y.-L. · Kuo H.-P.
Chemotherapy 2011;57:147–155 (DOI:10.1159/000321037)
Experimental Chemotherapy

Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial

Cereda S. · Reni M. · Rognone A. · Fugazza C. · Ghidini M. · Ceraulo D. · Brioschi M. · Nicoletti R. · Villa E.
Chemotherapy 2011;57:156–161 (DOI:10.1159/000324865)

3,5-Dimethyl-7H-Furo[3,2-g]Chromen-7-One as a Potential Anticancer Drug by Inducing p53-Dependent Apoptosis in Human Hepatoma HepG2 Cells

Sun J. · Chen C. · Luo K. · Yeung C.A. · Tsang T. · Huang Z. · Wu P. · Fung K. · Kwok T. · Liu F.
Chemotherapy 2011;57:162–172 (DOI:10.1159/000326915)
Experimental Chemotherapy

Effect of Ambroxol on Pneumonia Caused by Pseudomonas aeruginosa with Biofilm Formation in an Endotracheal Intubation Rat Model

Li F. · Wang W. · Hu L. · Li L. · Yu J.
Chemotherapy 2011;57:173–180 (DOI:10.1159/000323622)